BYY-96286-97594
2 vaccinations
3 coded responses
25 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 319 / GA
- Registered
- 2022-12-15
- Relationship
- Child or adolescent in my care
- Guardian
- WEC-11856-73176
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-12-15
Registered in v-safe
-
2022-12-15
Dose 1 — Pfizer-BioNTech
-
2022-12-15
Health check-in — day 0, dose 1, under 3Feeling: Fair · Fever · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-12-16
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Fever · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-12-17
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetite, DiarrheaUnder 3 check-in
-
2022-12-18
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Sleepiness, Irritability/crying, Loss of appetiteUnder 3 check-in
-
2022-12-19
Survey response — days 1–6 daily, dose 1, under 3MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetiteFree text: Her father and I tested positive for covidMedDRA releases: 2024-11 · check-in free text available
-
2022-12-21
Survey response — days 1–6 daily, dose 1, under 3MedDRA: SARS-CoV-2 test positive — Feeling: Good · Sleepiness, Irritability/cryingFree text: Tested positive for COVID-19 Dec 20, 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-12-22
Health check-in — day 7, dose 1, under 3Feeling: Good · Sleepiness, Irritability/crying, DiarrheaUnder 3 check-in
- 2022-12-29
- 2023-01-05
- 2023-01-12
- 2023-01-19
- 2023-01-26
-
2023-03-18
Dose 2 — Pfizer-BioNTech
- 2023-03-18
- 2023-03-18
- 2023-03-20
- 2023-03-22
- 2023-03-23
- 2023-03-24
- 2023-03-25
- 2023-04-01
- 2023-04-08
- 2023-04-17
- 2023-04-22
- 2023-04-29
-
2023-06-17
Survey response — 3 months, dose 2, under 3MedDRA: Ear infection, Nasopharyngitis, Office visit, Seasonal allergy — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-12-15 | Pfizer-BioNTech | No |
| 2 | 2023-03-18 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Her father and I tested positive for covid
Systemic reaction (other): Tested positive for COVID-19 Dec 20, 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Seasonal allergy | · | · | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release